Meta Is Testing a Prediction-Market App With Its Employees
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
On the night of November 13, 2026, Meta Platforms (NASDAQ:META | META Price Prediction) employees were asked to predict who would win the quiz show Jeopardy! inside an unreleased app called Takes. The test appeared that afternoon, and Meta declined to comment and gave no launch date.
Testers commit a points currency called cred, which they gain when a prediction is right and lose when it is wrong, and no money changes hands, which separates Takes from Kalshi and Polymarket, where users trade real dollars on outcomes.
Meta closed at $641.69, up $18.08 or 2.9%, then fell to $637.03 after hours, down 0.73% as of 7:59 p.m. ET. Nothing links the gain to the report, and shares remain down 13% over the past month. The question for shareholders is whether a free, habit-forming app can matter at a company whose family of apps reaches 3.64 billion[1] people daily.
Takes Has Changed Names Three Times Without Shipping
On June 23, 2026, reporting said Mark Zuckerberg directed a small team to build a points-based app called Arena. A day later, internal documents described it under the codenames Antwerp and FBForecast.
Those documents laid out a daily allocation of play money. Meta’s Llama AI model wrote questions from trending topics, recommended markets, and resolved them in near real time. Employees would test a prototype before a public launch on iPhone and Android.
Earlier reporting cited a goal of at least 100 million monthly participants aged 18 to 34, figures Meta itself has never stated.
Meta launched a crowdsourced prediction app called Forecast in 2020 and shut it down about two years later, with internal documents citing the cost of selecting questions by hand. Llama writing and settling questions targets that exact expense, which makes it the most meaningful change from the first attempt, and that suits an ad business, because what people choose to predict reveals their interests and brings them back daily.
Play Money Keeps Meta Clear of Regulators, at a Price
Real-money event contracts draw scrutiny from commodities regulators and state gaming regulators. A points game avoids both, although Meta waives trading fees, and players risking nothing tend to guess casually, which weakens the signal.
Listed peers moved without a stated cause on November 13. Robinhood Markets (NASDAQ:HOOD) fell 4.29% to $77.86, DraftKings (NASDAQ:DKNG) slipped 1.20% to $18.89, and CME Group (NASDAQ:CME) gained 0.78% to $317.97. A free Meta product would compete with them for attention and daily habit, which threatens Robinhood’s retail engagement far more than CME’s institutional futures franchise.
Internal Tests Deserve a Steep Discount
Like other dogfooded Meta products, meaning apps tested by its own staff, Takes could change names and features or never ship. Set against fourth-quarter revenue guidance of $73-76B[1] and 2026 capital spending of $135-145B, it is an option with no disclosed revenue.
That capex figure is the real story. For megacap tech investors, the suppliers behind the expansion, power, cooling, networking, are the ones we broke down in a free report on seven AI infrastructure names.
What Drives the Investment Case for META Stock
The investment case rests on advertising and AI. Third-quarter revenue rose 26.07%[1] to $64.60B, and more than 10 million[2] people set up Muse personal agents within about a month and a half of launch.
GAAP diluted EPS of $3.83[1] absorbed a $9.89B settlement charge, so the headline miss exaggerates the damage. Shares trade near 21 times earnings, with 55 Buy ratings against 1 Sell and an average target of $850.10. Spending is the real risk, since free cash flow was negative $2.1 billion[2] in the quarter.
Fourth-quarter revenue should land inside the $73-76B[1] range, and a close below the one-year low of $520.26 would signal the market has rejected the spending plan. A Takes listing in public app stores would add upside on top of that thesis.
Contact [email protected] for any questions or corrections.
Omor Ibne Ehsan is a writer at 24/7 Wall St. He is a self-taught investor with a focus on growth, cyclical, and dividend equities that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as penny stocks.
